Cost-effectiveness of oral anticoagulants versus aspirin in patients after infrainguinal bypass grafting surgery

Journal of Vascular Surgery

Volumn 34, Issue 2, 2001, Pages 254-262

  Oostenbrink, Jan B ^a,e   Tangelder, Marco J D ^b   Busschbach, Jan J V ^a   Van Hout, Ben A ^a   Buskens, Erik ^c   Algra, Ale ^c   Lawson, James A ^c   Eikelboom, Bert C ^d  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d AMSTELLAND HOSPITAL   (Netherlands)

^e NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HUMAN; LEG; MALE; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VASCULAR SURGERY; VASCULARIZATION;

AGED; ANTICOAGULANTS; ASPIRIN; COST-BENEFIT ANALYSIS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; LEG; MALE; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 0035432555     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2001.115961     Document Type: Article

References (17)

1. Tangelder MJD, Algra A, Lawson JA, Eikelboom BC. Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infra-inguinal bypass surgery J Vasc Surg 1999;30:701-9.
2. The Dutch Bypass oral anticoagulants or Aspirin (BOA) Study Group. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): a randomised trial. Lancet 2000;355:346-51.
3. Dolan P. Modeling valuations for the EuroQol health states. Med Care 1997;35:1095-108.
4. Tangelder M, McDonnell J, Busschbach J, Buskens E, Algra A, Lawson J, et al. Quality of life after infrainguinal bypass surgery. J Vasc Surg 1999;29:913-9.
5. Busschbach J, Tangelder M, McDonnell J, Buskens E, Algra A, Lawson J, et al. EuroQol values for economic modeling quality of life after infrainguinal bypass surgery, a rectification. J Vasc Surg 1999;30:1162.
6. van Haut B, van de Woude T, de Jaegere P, van de Brand M, van Es G, Serruys P, et al. Cost-effectiveness of stent implantation versus PTCA: the Benestent experience. Semin Interv Cardiol 1996;1:263-8.
7. van Dijk LC, Seerden R, van Urk H, Wittens CHA. Comparison of cost affecting parameters and costs of the "closed" and "open" in situ bypass technique. Eur J Vasc Endovasc Surg 1997;13:460-3.
8. Gorter JW, Oostenbrink JB, Tangelder MJD. Costs of outpatient anticoagulant treatment in patients with cerebral and peripheral arterial occlusive disease. Thromb Haemost 2001;85:52-6.
9. Severens J, de Boo T, Konst E. Uncertainty of incremental cost-effectiveness ratios: a comparison of Fieller and bootstrap confidence intervals. Int J Technol Assess Health Care 1999;15:608-14.
10. Briggs A, Fenn P. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Econ 1998;7:723-40.
11. Chaudhary MA, Stearns SC. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Stat Med 1996;15:1447-58.
12. van Hout B, Al M, Gordon G, Rutten F. Costs, effects and CE-ratios alongside a clinical trial. Health Econ 1994;3:309-19.
13. Gage B, Cardinalli A, Albers G, Owens D. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA 1995;274:1839-45.
14. Gustafsson C, Asplund K, Britton M, Norrving B, Olsson B, Marke L. Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective. BMJ 1992;305:1457-60.
15. Gianetti J, Gensini G, De Caterina R. Cost-effective ness analysis of aspirin versus oral anticoagulants after myocardia infarction in Italy. Thromb Haemost 1998;80:887-93.
16. Gage B, Cardinalli A, Owens D. Cost-effectiveness of preference-based antithrombotic therapy for patients with no valvular atrial fibrillation. Stroke 1998;29:1083-91.
17. Cairns J, Markham B. Economics and efficacy in choosing oral anticoagulants or aspirin after myocardial infarction. JAMA 1995;273:965-7.